ArticleOncology letters2026

Focal adhesion kinase inhibitor defactinib enhances olaparib-induced suppression of BRCA-proficient breast cancer cell proliferation.

Hisako Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.